Completed PHASE1 INTERVENTIONAL 1-arm NCT00955669

Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer

Comparison of Autologous Transplantation of Bone Marrow Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer

Sponsor: Third Military Medical University

Conditions Autologous Transplantation Diabetic Foot

Interventions Symptoms and Objective Examination

Updated 5 times since 2017 Last updated: Nov 30, 2010 Started: Aug 31, 2009 Primary completion: Aug 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Autologous Transplantation and Diabetic Foot, this trial is completed. The trial is conducted by Third Military Medical University and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Third Military Medical University

Data source: Third Military Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chongqing, China